Key Highlights

● Blue Hat's closing bid price was $0.10 or less for ten consecutive trading days through March 6, 2026, Nasdaq said.

● Trading was due to be suspended on March 16, 2026, and the company requested a hearing before the Nasdaq panel.

● The company has repositioned from augmented reality games to commodity trading across diamond trading, commodity trading and information services segments.

● 2024 revenue fell 74.59% to $18.72 million, while the net loss improved 50.64% to $9.52 million.

Blue Hat Interactive Entertainment Technology (OTC:BHATF) is a Cayman Islands exempted company based in Xiamen, China. Once a developer of augmented reality entertainment games and educational materials, it has repositioned as a commodity trader, and its shares now trade over the counter as BHATF after a Nasdaq delisting process.

Data providers still classify it under communication services and electronic gaming, a legacy of the original business.

Moving from entertainment software to physical and financial commodity trading brings different working capital needs, counterparty exposures and regulatory obligations.

Business model

Market data describes bulk commodity trading in China and Malaysia through three segments: diamond trading, commodity trading and information services. Activities include chemical products such as ethanol, jewellery, and gold supply chain and derivatives services. Market data describes a holding company in gold and diamond trading, supply chain business and AI-enabled trading platforms, with about 14 employees.

The company's March 2026 release stated its aim of becoming a leading intelligent commodity trader worldwide. Market data also reports that the acquisition of Lanjin Technology Co., Ltd. completed in July 2025, though that detail comes from a single data summary.

Delisting notice and capital actions

On March 9, 2026 Blue Hat received a Nasdaq letter stating that it breached Listing Rule 5810(c)(3)(A)(iii), because its closing bid price was $0.10 or less for ten consecutive trading days from February 23 to March 6, 2026. The company had regained minimum bid compliance on April 2, 2025. Trading was due to be suspended at the open on March 16, 2026, and the company said it had requested a hearing before the Nasdaq hearings panel while cautioning that success was not assured.

Market data also lists a $6.4 million public offering priced in February 2026, a one-for-fifty reverse split announced after an earlier postponement, and a $1 million repurchase authorisation in March 2026. The sequence and completion of these steps are not verified from primary filings.

Financial performance

For 2024, market data reports revenue of $18.72 million, a fall of 74.59%, and a net loss of $9.52 million, an improvement of 50.64%. Market data gives 2023 revenue as $73.69 million. Trailing twelve-month revenue is shown at $18.97 million. All figures are third-party summaries in U.S. dollars, and no 2025 annual results have been located.

Price data are unreliable as a guide. The 52-week range spans from $0.000001 to $102.50, which reflects the reverse split, and the quoted market capitalisation differs sharply between providers, from a few hundred dollars to about $8.4 million. Neither figure can be tied to a confirmed share count.

Market data shows 3.10 million shares outstanding, which is consistent with a heavily consolidated share base, but the figure has not been matched to a filing. The sharp fall in sales from 2023 to 2024 also shows how volatile trading revenue can be when it depends on a small number of large transactions.

The Nasdaq Hearing and Segment Profitability Will Test Blue Hat's Pivot

Key risks include the loss of an exchange listing, a business pivot into low-margin trading with heavy dependence on counterparties, and a sharp revenue decline. Minimum bid price problems have recurred here. Over-the-counter liquidity is limited and quotes can move violently on small volume.

Open items include the outcome of the Nasdaq hearing, any annual report on Form 20-F or equivalent for 2025, confirmation of the current OTC tier and reporting status, and evidence of segment profitability.